Choose a country to view content specific to your location
Choose a country to view content specific to your location
Key opinion leader, Donna Mayne, B.S. (MT) ASCP, (CLS) NCA, presents on the topic of Group B Streptococcus. She discusses disease state, guidelines for testing and testing options.
Speaker: Donna Mayne, B.S. MT(ASCP), CLS(NCA), Microbiology/ Serology/ Molecular Diagnostics Laboratory Manager Sacred Heart Hospital, Pensacola, FL
Group B Streptococcus continues to be the leading cause of morbidity and mortality in infants. This program will provide a comprehensive overview of this pathogen and the 2010 CDC guidelines that address diagnosis and prevention.
Speaker: Paul Granato, Ph.D., DABMN, FAAM. Professor of Pathology and Microbiology – SUNY Upstate Medical University. Director of Microbiology – Laboratory Alliance of Central New York, Syracuse, NY Consultant Clinical Microbiologist – Centrex Clinical Laboratories, Utica, NY
Key opinion leader, James M. Greenberg, MD Professor and Director, Division of Neonatology, Cincinnati Children’s Hospital Medical Center, presents on the topic of neonatal Group B Streptococcal disease. Group B Streptococcus continues to be the leading cause of morbidity and mortality in infants. This program will provide a comprehensive overview of this pathogen and the 2010 CDC guidelines that address diagnosis and prevention.
Speaker: James M. Greenberg, MD, Professor and Director, Division of Neonatology Section of Neonatology, Perinatal and Pulmonary Biology Department of Pediatrics, Co-Director, CCHMC Perinatal Institute, Cincinnati Children’s Hospital Medical Center.
Key opinion leader, Haywood Brown, MD, Professor and Chair, Obstetrics, Gynecology and Maternal Fetal Medicine
Duke Medicine, Durham, NC, presents on the topic of Group B Streptococcal disease. Group B Streptococcus continues to be the leading cause of morbidity and mortality in infants. This program will provide a comprehensive overview of this pathogen and the 2010CDC guidelines that address diagnosis and prevention.
Speaker: Haywood Brown, MD. Professor and Chair Obsterics, Gynecology and Maternal Fetal Medicine – Duke Medicine, Durham, NC
Key Opinion leader Jennifer Dien Bard, Ph.D., D(ABMM), FCCM discusses Group A Streptococcus continues to be the number one cause of acute bacterial pharyngitis. This program will provide a comprehensive overview of this pathogen and the benefits of molecular detection along with the 2012 IDSA Guidelines that address diagnosis and treatment.
Speaker:
Jennifer Dien Bard, Ph.D., D(ABMM), FCCM, M(ASCP)CM
Assistant Professor – Clinical Pathology Keck School of Medicine, University of Southern California
Director – Clinical Microbiology Laboratory Department of Pathology and Laboratory Medicine,
Acting Director – Clinical Virology Laboratory Children’s Hospital of Los Angeles.
This program provides a comprehensive review of recent E. coli non-O157 outbreaks in Oklahoma and Germany. A full review of the lessons learned, as well as the testing changes that were prompted as a result of these outbreaks will be covered.
Speaker: Michael B. Lytle, BS, M(ASCP) Supervisory Microbiology, Laboratory Bioterrorism Coordinator, Oklahoma State Department of Health Public Health Laboratory
Key opinion leader, Michael B. Lytle, BS, M(ASCP) provides a comprehensive review of Shiga toxin producing E. coli including modes of transmission, symptoms, and virulence factors. This webinar will also discuss the advantages and disadvantages of the different test methods currently available.
Speaker: Michael B. Lytle, BS, M(ASCP), Supervisory Microbiology, Laboratory Bioterrorism Coordinator, Oklahoma State Department of Health Public Health Laboratory.
Broth enrichment for Shiga toxin IS recommended by the CDC
Direct stool testing for Shiga toxin is NOT recommended by the CDC:
– Direct stool testing DISREGARDS the CDC Guidelines with the promotion of direct testing of EHEC patients
-Direct stool testing can lead to missed positives (false negatives) – this creates unnecessary use of contraindicated antibiotics
– EHEC results can be a matter of life and DEATH, direct testing is not worth the risk as a standard of care
Speaker: Michael B. Lytle, BS, M(ASCP) Supervisory Microbiology – Laboratory Bioterrorism Coordinator – Oklahoma State Department of Health Public Health Laboratory
Meridian offers diagnostic manufacturers the complete solution with over 3,000 antigens and antibodies covering more than 500 diseases and an extensive range of specialty qPCR/RT-qPCR master mixes and molecular enzymes all manufactured under ISO13485 regulations.
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
